Mehmed Fatih Canatan
Research Subjects
Research Interests
Mehmed Fatih Canatan has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Eken
Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Türkiye
2 shared publications - Ahmet Ozen
Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey
2 shared publications - Alper Ozcan
Erciyes University Faculty of Medicine, Department of Pediatrics Hematology and Oncology, Kayseri, Türkiye
2 shared publications - Aydan Ikinciogullari
Department of Pediatric Immunology and Allergy, Ankara University Medical School, Ankara, Turkey
2 shared publications - Can Berk Leblebici
Department of Medical Genetics, Faculty of Medicine, Ankara University, Ankara, Turkey
2 shared publications - Ebru Yilmaz
Erciyes University Faculty of Medicine, Department of Pediatrics Hematology and Oncology, Kayseri, Türkiye
2 shared publications
Latest Publications
- Open Access
- 16 November 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 45 (1) , 1-2
Correction to: DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
- 16 November 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 45 (1) , 1-2
Open AccessCorrection to: DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
- Open Access
- 9 August 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (8) , 1-17
DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
Loss of function mutations in Diaphanous related formin 1 (DIAPH1) are associated with seizures, cortical blindness, and microcephaly syndrome (SCBMS) and are recently linked to combined immunodeficiency. However, the extent of defects in T and innate lymphoid cells (ILCs) remain unexplored. Herein, we characterized the primary T, natural killer (NK) and helper ILCs of six patients carrying two novel loss of function mutation in DIAPH1 and Jurkat cells after DIAPH1 knockdown. Mutations were identified by whole exome sequencing. T-cell immunophenotyping, proliferation, migration, cytokine signaling, survival, and NK cell cytotoxicity were studied via flow cytometry-based assays, confocal microscopy, and real-time qPCR. CD4+ T cell proteome was analyzed by mass spectrometry. p.R351* and p.R322*variants led to a significant reduction in the DIAPH1 mRNA and protein levels. DIAPH1-deficient T cells showed proliferation, activation, as well as TCR-mediated signaling defects. DIAPH1-deficient PBMCs also displayed impaired transwell migration, defective STAT5 phosphorylation in response to IL-2, IL-7 and IL-15. In vitro generation/expansion of Treg cells from naïve T cells was significantly reduced. shRNA-mediated silencing of DIAPH1 in Jurkat cells reduced DIAPH1 protein level and inhibited T cell proliferation and IL-2/STAT5 axis. Additionally, NK cells from patients had diminished cytotoxic activity, function and IL-2/STAT5 axis. Lastly, DIAPH1-deficient patients’ peripheral blood contained dramatically reduced numbers of all helper ILC subsets. DIAPH1 deficiency results in major functional defects in T, NK cells and helper ILCs underlining the critical role of formin DIAPH1 in the biology of those cell subsets. Graphical Abstract
- 9 August 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (8) , 1-17
Open AccessDIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
Loss of function mutations in Diaphanous related formin 1 (DIAPH1) are associated with seizures, cortical blindness, and microcephaly syndrome (SCBMS) and are recently linked to combined immunodeficiency. However, the extent of defects in T and innate lymphoid cells (ILCs) remain unexplored. Herein, we characterized the primary T, natural killer (NK) and helper ILCs of six patients carrying two novel loss of function mutation in DIAPH1 and Jurkat cells after DIAPH1 knockdown. Mutations were identified by whole exome sequencing. T-cell immunophenotyping, proliferation, migration, cytokine signaling, survival, and NK cell cytotoxicity were studied via flow cytometry-based assays, confocal microscopy, and real-time qPCR. CD4+ T cell proteome was analyzed by mass spectrometry. p.R351* and p.R322*variants led to a significant reduction in the DIAPH1 mRNA and protein levels. DIAPH1-deficient T cells showed proliferation, activation, as well as TCR-mediated signaling defects. DIAPH1-deficient PBMCs also displayed impaired transwell migration, defective STAT5 phosphorylation in response to IL-2, IL-7 and IL-15. In vitro generation/expansion of Treg cells from naïve T cells was significantly reduced. shRNA-mediated silencing of DIAPH1 in Jurkat cells reduced DIAPH1 protein level and inhibited T cell proliferation and IL-2/STAT5 axis. Additionally, NK cells from patients had diminished cytotoxic activity, function and IL-2/STAT5 axis. Lastly, DIAPH1-deficient patients’ peripheral blood contained dramatically reduced numbers of all helper ILC subsets. DIAPH1 deficiency results in major functional defects in T, NK cells and helper ILCs underlining the critical role of formin DIAPH1 in the biology of those cell subsets. Graphical Abstract